Aspira Women's Health Inc.
AWHL
$0.4196
$0.00962.34%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 4.10% | 3.53% | 0.31% | -2.33% | -1.21% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.10% | 3.53% | 0.31% | -2.33% | -1.21% |
Cost of Revenue | -10.93% | -5.89% | -4.86% | -3.60% | -3.54% |
Gross Profit | 15.06% | 10.11% | 4.12% | -1.40% | 0.57% |
SG&A Expenses | -18.91% | -8.63% | -8.00% | -13.25% | -23.43% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -18.13% | -8.21% | -9.09% | -10.49% | -21.10% |
Operating Income | 29.56% | 14.32% | 13.65% | 14.27% | 28.50% |
Income Before Tax | 40.74% | 30.00% | 21.55% | 18.67% | 24.99% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 40.74% | 30.00% | 21.55% | 18.67% | 24.99% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 40.74% | 30.00% | 21.55% | 18.67% | 24.99% |
EBIT | 29.56% | 14.32% | 13.65% | 14.27% | 28.50% |
EBITDA | 29.37% | 13.97% | 13.23% | 13.84% | 28.28% |
EPS Basic | 67.33% | 52.87% | 46.57% | 42.91% | 44.56% |
Normalized Basic EPS | 60.63% | 50.61% | 45.31% | 43.40% | 44.88% |
EPS Diluted | 67.33% | 52.87% | 46.57% | 42.96% | 44.66% |
Normalized Diluted EPS | 60.63% | 50.61% | 45.31% | 43.40% | 44.88% |
Average Basic Shares Outstanding | 100.40% | 63.81% | 53.09% | 44.24% | 35.73% |
Average Diluted Shares Outstanding | 100.40% | 63.81% | 53.09% | 44.24% | 35.73% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |